Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Transcriptomic and genomic characteristics of intrahepatic metastases of primary liver cancer

View through CrossRef
Abstract Background Patients with primary multifocal hepatocellular carcinoma (HCC) have a poor prognosis and often experience a high rate of treatment failure. Multifocal HCC is mainly caused by intrahepatic metastasis (IM), and though portal vein tumor thrombosis (PVTT) is considered a hallmark of IM, the molecular mechanism by which primary HCC cells invade the portal veins remains unclear. Therefore, it is necessary to recognize the early signs of metastasis of HCC to arrange better treatment for patients. Results To determine the differential molecular features between primary HCC with and without phenotype of metastasis, we used the CIBERSORTx software to deconvolute cell types from bulk RNA-Seq based on a single-cell transcriptomic dataset. According to the relative abundance of tumorigenic and metastatic hepatoma cells, VEGFA+ macrophages, effector memory T cells, and natural killer cells, HCC samples were divided into five groups: Pro-T, Mix, Pro-Meta, NKC, and MemT, and the transcriptomic and genomic features of the first three groups were analyzed. We found that the Pro-T group appeared to retain native hepatic metabolic activity, whereas the Pro-Meta group underwent dedifferentiation. Genes highly expressed in the group Pro-Meta often signify a worse outcome. Conclusions The HCC cohort can be well-typed and prognosis predicted according to tumor microenvironment components. Primary hepatocellular carcinoma may have obtained corresponding molecular features before metastasis occurred.
Title: Transcriptomic and genomic characteristics of intrahepatic metastases of primary liver cancer
Description:
Abstract Background Patients with primary multifocal hepatocellular carcinoma (HCC) have a poor prognosis and often experience a high rate of treatment failure.
Multifocal HCC is mainly caused by intrahepatic metastasis (IM), and though portal vein tumor thrombosis (PVTT) is considered a hallmark of IM, the molecular mechanism by which primary HCC cells invade the portal veins remains unclear.
Therefore, it is necessary to recognize the early signs of metastasis of HCC to arrange better treatment for patients.
Results To determine the differential molecular features between primary HCC with and without phenotype of metastasis, we used the CIBERSORTx software to deconvolute cell types from bulk RNA-Seq based on a single-cell transcriptomic dataset.
According to the relative abundance of tumorigenic and metastatic hepatoma cells, VEGFA+ macrophages, effector memory T cells, and natural killer cells, HCC samples were divided into five groups: Pro-T, Mix, Pro-Meta, NKC, and MemT, and the transcriptomic and genomic features of the first three groups were analyzed.
We found that the Pro-T group appeared to retain native hepatic metabolic activity, whereas the Pro-Meta group underwent dedifferentiation.
Genes highly expressed in the group Pro-Meta often signify a worse outcome.
Conclusions The HCC cohort can be well-typed and prognosis predicted according to tumor microenvironment components.
Primary hepatocellular carcinoma may have obtained corresponding molecular features before metastasis occurred.

Related Results

Liver metastases reprogram neutrophils to potentiate cancer progression
Liver metastases reprogram neutrophils to potentiate cancer progression
Abstract Liver metastases are associated with poor overall survival and increased disease progression, regardless of primary tumor type. Liver metastases suppress sy...
Abstract 2094: Regulation of site-specific liver metastasis by collagen IV-conveyed signals
Abstract 2094: Regulation of site-specific liver metastasis by collagen IV-conveyed signals
Abstract The liver is a primary site of metastasis for some of the most common human malignancies. At present, surgical resection is the most effective curative opti...
Prognostic factors in hormone receptor positive oligometastatic breast cancer.
Prognostic factors in hormone receptor positive oligometastatic breast cancer.
1058 Background: Some recommend curative treatment for oligometastatic breast cancer (OMBC). To date, no randomized clinical trial has demonstrated the benefits of such a strategy...
Abstract 7197: Elacridar sensitizes liver cancer to the PKC-inhibitor ICA-1S
Abstract 7197: Elacridar sensitizes liver cancer to the PKC-inhibitor ICA-1S
Abstract Liver cancer is a disease in which cancer cells form in the tissues of the liver. Globally, liver cancer is one of the most frequent fatal malignancies; in ...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma Aims: The c‐erbB‐2 and c‐Met proto‐oncogenes are important for ...
Surgical strategy for neuroendocrine liver metastases
Surgical strategy for neuroendocrine liver metastases
IntroductionThere are no established strategies for the surgical management of neuroendocrine liver metastases. Surgical treatment options include liver resection, liver transplant...
Liver Cancer Prediction Using Machine Learning: Enhancing Early Detection and Survival Analysis
Liver Cancer Prediction Using Machine Learning: Enhancing Early Detection and Survival Analysis
Liver cancer is still one of the most lethal cancers in the world, with consistently increasing rates in the United States that are caused by rising rates of obesity, rates of hepa...

Back to Top